Cambridge Epigenetix Ltd
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cambridge Epigenetix Ltd
Cambridge Epigenetix Ltd. (CEGX) has appointed two new senior executives to help drive development of its epigenetics-based diagnostic technologies. Hayden Jeffreys joins the company as COO and Joanne Mason as vice president of biomarker discovery.
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bi-monthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in March and April 2017.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced February through March 2016.
Surgical Equipment & Devices
- Minimally or Less Invasive
- Surgical Equipment & Devices